Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. 2024-05-01 Health moderate FDA
Health · FDA · Recall #FDA-D-0468-2024
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka… Recall
Issued May 1, 2024 · Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
In May 2024, Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalled the Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Cross Contamination with Other Products
What you should do
- 1 Stop using Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Category
- Health
- Recall date
- May 1, 2024
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0468-2024
- Made in
- Japan
- Issuing agency
- FDA
In context
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.